Skip to main content

Animations

MJFF Publications

6651 - 6660 of 8654 Results
Title
Year
  • Year
  • 2020
  • 2016
  • 2017
  • 2013
  • 2016
  • 2016
  • 2022
  • 2021
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: The In Situ Structure of Parkinson’s Disease-Linked LRRK2
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cell.2020.08.004
    Citation Count: 192
  • Summary Details
    OPEN
    Title: Progression of Regional Microstructural Degeneration in Parkinson’s Disease: A Multicenter Diffusion Tensor Imaging Study
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0165540
    Citation Count: 89
  • Summary Details
    OPEN
    Title: Cocaine and desipramine elicit distinct striatal noradrenergic and behavioral responses in selectively bred obesity-resistant and obesity-prone rats
    Journal Name: Behavioural Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbr.2017.11.009
    Citation Count: 3
  • Summary Details
    OPEN
    Title: The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.021
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Regional volumetric change in Parkinson's disease with cognitive decline
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.jns.2016.12.030
    Citation Count: 27
  • Summary Details
    OPEN
    Title: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2
    Citation Count: 199
  • Summary Details
    OPEN
    Title: Elevation of gangliosides in four brain regions from Parkinson’s disease patients with a GBA mutation
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00363-2
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02316-0
    Citation Count: 71
  • Summary Details
    OPEN
    Title: LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1007/s13311-021-01007-8
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Remote Digital Monitoring for Medical Product Development
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/cts.12851
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.